Two biotech companies are now suing Moderna over their COVID vaccine. They are claiming seven counts of patent infringement.
Two biotech companies filed a lawsuit against Moderna on Monday, alleging that the vaccine manufacturer had infringed on patented technology when it developed its COVID-19 vaccine.
Arbutus Biopharma and Genevant Sciences allege in their civil lawsuit that Moderna was able to quickly develop a coronavirus vaccine thanks to “breakthrough technology Arbutus had already created and patented,” namely the lipid nanoparticle delivery system that is used in the shot.
Genevant is spearheaded by former Arbutus scientists. The Switzerland-based company licenses lipid nanoparticle platform intellectual property from Arbutus.
“Moderna was well aware of Arbutusâ€™s LNP patents and licensed them for other product programs, but it chose not to do so for its COVID-19 vaccine. Instead, it attempted to invalidate several of the patents before the United States Patent and Trademark Office, and when those efforts largely failed, Moderna simply used the patented technology without paying for it or even asking for a license,” the complaint read.
Moderna denies the allegations saying in a statement “Moderna denies these allegations, and will vigorously defend itself against Genevantâ€™s claims in Court.”
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.Â
Follow us on social media:
Listen to our Daily News Podcast!